The draft Order published at the official website of the Federal Customs Service (FCS) announces reduction of the number of customs posts eligible for clearing the pharmaceuticals (from 20 to 4 posts).
In particular, it is intended to keep operating: the Lytkarinsky post (the warehouse of “Items-Warehouses” logistics provider), the Davydovsky post (“Farmat”), the Department for customs clearance and customs control # 2 of the Davydovsky customs post (“Norston”) and the Mamontovsky post (“The customs warehouse TransService” owned by Protek Group).
The five-fold cut-down of customs posts might result in disruptions in drugs supplies.
The FCS Order is currently under review of the Ministry of Justice and, if approved, it will be registered and enforced within 30 days after publishing in "Rossiyskaya Gazeta". As per the FCS, practically the number of customs posts is going to be cut in May.
The President of Russia Dmitry Medvedev has signed the Federal law “On introducing amendments into the Federal law “On State Tenders”.
The law is aimed at improving the activities of the federal, regional and local state authorities with respect to placing orders for supply of goods, works and services for state and municipal needs, ensuring the publicity and transparency of orders placement, preventing corruption and other abuses.
The President had instructed the Russian Government to develop until June 1, 2011 the methodology for forming the List of Essential Drugs, based on the adopted standards of medical care.
The Russian Government was also requested to present suggestions for improving the existent methodology for determining the maximum manufacturers’ prices for essential drugs. The Prime Minister of Russia Vladimir Putin was assigned to be responsible in this respect.
In addition, the President instructed the Minister of Health and Social Development of Russia Tatiana Golikova to issue by June 1, 2011 the normative acts specifying the requirements to the content and completion of the documents required for compiling a pharmaceutical dossier.
As per the announcement of the Prime Minister of Russia Vladimir Putin, 17 research centers for development of pharmaceuticals and medical equipment are to be established in Russia.
According to the Prime Minister, it is planned to invest 120 billion Rubles into developing the pharmaceutical sector by 2020. The respective expenditures are presumed by the Federal program for development of the pharmaceutical industry until 2020.
© 2021 KPMG refers JSC “KPMG”, “KPMG Tax and Advisory” LLC, companies incorporated under the Laws of the Russian Federation, and KPMG Limited, a company incorporated under The Companies (Guernsey) Law, as amended in 2008, member firms of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organization please visit https://home.kpmg/governance.